divislab glp-1 novo nordisk A $60 billion industry just found its next growth lever. ๐ With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Novo inks Ascendis deal to
Pay in 4 interest-free payments of $6.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 10 - Oct 15



/assets/images/provider/photos/2775922.jpeg)






















